Watch these videos to learn more about POMALYST® (pomalidomide).
Follow the steps in this video to learn how you receive your POMALYST prescription. You can learn more about the POMALYST Risk Evaluation and Mitigation Strategy (REMS) program here.
On-Screen Super: POMALYST® (pomalidomide) is a prescription medicine, taken along with the medicine dexamethasone, used to treat adults with multiple myeloma who have previously received at least 2 medicines to treat multiple myeloma, including a proteasome inhibitor and lenalidomide, and whose disease has become worse during treatment or within 60 days of finishing the last treatment. It is not known if POMALYST is safe and effective in children.
On-Screen Super: POMALYST has a Black Box Warning. The warning is there because POMALYST may cause serious side effects, including possible birth defects (deformed babies) or death of an unborn baby, and blood clots in your arteries, veins, lungs, heart attack, and stroke. Because of these safety considerations, POMALYST is only available through a restricted distribution program called POMALYST REMS®.
Please see below this video for Important Safety Information about POMALYST.
On-Screen Super: Getting My Medication
VO: Getting My Medication. To avoid serious risks to unborn babies, POMALYST is only available through a restricted distribution program called
On-Screen Super: POMALYST Risk Evaluation and Mitigation Strategy
VO: POMALYST Risk Evaluation and Mitigation Strategy. It’s also known as the POMALYST REMS program.
On-Screen Super: POMALYST REMS®
VO: For those who have already been prescribed REVLIMID, also known as lenalidomide, getting your POMALYST prescription is the same process. Before you begin taking POMALYST, you must be enrolled in the POMALYST REMS program. Once you complete your counseling and enrollment with your healthcare provider, you will need to take the following steps to receive your prescription:
On-Screen Super: POMALYST REMS®
VO: Step 1. TAKE YOUR POMALYST REMS SURVEY
On-Screen Super: Ways to take your survey:
Important Safety Information
What is POMALYST® (pomalidomide)?
POMALYST is a prescription medicine, taken along with the medicine dexamethasone, used to treat adults with multiple myeloma who have previously received at least 2 medicines to treat multiple myeloma, including a proteasome inhibitor and lenalidomide, and whose disease has become worse during treatment or within 60 days of finishing the last treatment. It is not known if POMALYST is safe and effective in children.
WARNINGS: Risk to unborn babies, and blood clots.
What is the most important information I should know about POMALYST?
Before you begin taking POMALYST, you must read and agree to all of the instructions in the POMALYST REMS® program. Before prescribing POMALYST, your healthcare provider (HCP) will explain the POMALYST REMS program to you and have you sign the Patient-Physician Agreement Form.
POMALYST can cause serious side effects, including:
There is a pregnancy exposure registry that monitors the outcomes of females who take POMALYST during pregnancy, or if their male partner takes POMALYST and they are exposed during pregnancy. You can enroll in this registry by calling Celgene Corporation at the phone number listed above.
Men, if your female partner becomes pregnant, you should call your healthcare provider right away.
Call your healthcare provider or get medical help right away if you get any of the following during treatment with POMALYST:
Get emergency medical help right away if you develop any of the following signs or symptoms during treatment with POMALYST:
Who should not take POMALYST?
Do not take POMALYST if you:
What should I tell my healthcare provider (HCP) before taking POMALYST?
How should I take POMALYST?
Take POMALYST exactly as prescribed and follow all the instructions of the POMALYST REMS program.
What are the possible side effects of POMALYST?
Please see full Prescribing Information, including Boxed WARNINGS and Medication Guide.
POMALYST® and POMALYST REMS® are registered trademarks of Celgene Corporation, a Bristol Myers Squibb company.
© 2022 Bristol-Myers Squibb Company. 1/22 2204-US-2100202
Follow the steps in this video to learn how you receive your POMALYST prescription. You can learn more about the POMALYST Risk Evaluation and Mitigation Strategy (REMS) program here.
Download our Getting My Medication brochure for helpful information regarding how to receive your medication.
DownloadSee how POMALYST works to help fight relapsed/refractory multiple myeloma (RRMM).
On-Screen Super: POMALYST® (pomalidomide) is a prescription medicine, taken along with the medicine dexamethasone, used to treat adults with multiple myeloma who have previously received at least 2 medicines to treat multiple myeloma, including a proteasome inhibitor and lenalidomide, and whose disease has become worse during treatment or within 60 days of finishing the last treatment. It is not known if POMALYST is safe and effective in children.
On-Screen Super: POMALYST has a Black Box Warning because it may cause serious side effects. These side effects, including possible birth defects (deformed babies) or death of an unborn baby, and blood clots in your arteries, veins, lungs, heart attack, and stroke. Because of these safety considerations, POMALYST is only available through a restricted distribution program called POMALYST REMS®.
Please see below this video for important Safety Information about POMALYST.
VO: How POMALYST Works.
VO: POMALYST is a prescription medication used to treat relapsed/refractory multiple myeloma, or RRMM for short.
VO: It is a capsule that is taken once daily.
VO: POMALYST is an immunomodulatory (IMiD) agent.
VO: This means it works with your immune system to fight relapsed/refractory multiple myeloma.
VO: If your MM stops responding to lenalidomide and a proteasome inhibitor (PI),
VO: POMALYST with dexamethasone may help.
VO: POMALYST, when taken in combination with dexamethasone, is thought to work in 3 ways in animal models and in vitro. In vitro means in a test tube or glass; outside of a living organism.
VO: It STIMULATES your immune system and helps it recognize and destroy myeloma cells.
VO: It STRIKES by targeting and killing the myeloma cells.
VO: And it STARVES the myeloma cells and prevents them from growing.
VO: Ask your doctor if POMALYST may be right for you.
VO: Be sure to always follow your doctor’s instructions carefully about how to take POMALYST.
VO: And talk with your doctor or nurse if you have any questions.
Indication VO:
Important Safety Information
What is POMALYST® (pomalidomide)?
POMALYST is a prescription medicine, taken along with the medicine dexamethasone, used to treat adults with multiple myeloma who have previously received at least 2 medicines to treat multiple myeloma, including a proteasome inhibitor and lenalidomide, and whose disease has become worse during treatment or within 60 days of finishing the last treatment. It is not known if POMALYST is safe and effective in children.
WARNINGS: Risk to unborn babies, and blood clots.
What is the most important information I should know about POMALYST?
Before you begin taking POMALYST, you must read and agree to all of the instructions in the POMALYST REMS® program. Before prescribing POMALYST, your healthcare provider (HCP) will explain the POMALYST REMS program to you and have you sign the Patient-Physician Agreement Form.
POMALYST can cause serious side effects, including:
There is a pregnancy exposure registry that monitors the outcomes of females who take POMALYST during pregnancy, or if their male partner takes POMALYST and they are exposed during pregnancy. You can enroll in this registry by calling Celgene Corporation at the phone number listed above.
Men, if your female partner becomes pregnant, you should call your healthcare provider right away.
Call your healthcare provider or get medical help right away if you get any of the following during treatment with POMALYST:
Get emergency medical help right away if you develop any of the following signs or symptoms during treatment with POMALYST:
Who should not take POMALYST?
Do not take POMALYST if you:
What should I tell my healthcare provider (HCP) before taking POMALYST?
How should I take POMALYST?
Take POMALYST exactly as prescribed and follow all the instructions of the POMALYST REMS program.
What are the possible side effects of POMALYST?
Please see full Prescribing Information, including Boxed WARNINGS and Medication Guide.
POMALYST® and POMALYST REMS® are registered trademarks of Celgene Corporation, a Bristol Myers Squibb company.
© 2022 Bristol-Myers Squibb Company. 1/22 2204-US-2100203
See how POMALYST works to help fight relapsed/refractory multiple myeloma (RRMM).
Download our Conversation Starter to find ways to talk about POMALYST.
DownloadNot an actual patient.
This website is best viewed
using the horizontal display
on your tablet device.
This website is best viewed
using the vertical display
on your mobile device.